CLSPN and prostate carcinoma: In vitro inhibition of Claspin expression decreased cell proliferation [99,100] and stimulated apoptosis [100], features consistent with the role of Claspin in cell cycle checkpoint signaling and cell-fate decisions, and restored the sensitivity to treatment of docetaxel-resistant prostate cancer cells [99].